About this event

  • Date and time Tue 26 Apr 2022 from 4:30pm to 28 Apr 2022 at 6:00pm
  • Location Online
  • Organised by Endocrinology and Diabetes

This meeting is being held as a webinar series over three evenings to methodically allow participants to learn epidemiology, clinical care, novel therapeutics and biomarkers in non-alcoholic fatty liver disease (NAFLD) and diabetes. There will be an exciting panel discussion with enthusiastic world-class speakers and experts. 

Join these webinars to discover the burden of NAFLD in general and within the diabetes population, and to understand the importance of a multidisciplinary approach to the treatment of NAFLD and diabetes. Participants will have the opportunity to interact and contribute to the discussion with specialists in their fields regarding clinical cases where there was diagnostic uncertainty or management difficulty.

These webinars are held in association with the RSM Gastroenterology and Hepatology Section, ABCD and SfE.

Learning objectives include:

  • Understand histopathology in NAFLD and the effect that diabetes therapies have on the liver 
  • Understand the key scoring systems, diagnostic approaches and imaging techniques in NAFLD 
  • Obtain an understanding of the current state of the art of research in NAFLD   
  • Gain up to date knowledge of the effect of the microbiome in NAFLD 

Join in the conversation online
Follow us on Twitter: @RoySocMed 

We would like to thank our sponsor Novo Nordisk for their support of this meeting.
Please note that the scientific programme and content has not been influenced in any way by the sponsor.


View the programme 26 April 2022

Welcome and introduction

Dr Sheba Jarvis, Consultant in Diabetes and Endocrinology and Professor Ketan Dhatariya, Consultant in Diabetes and Endocrinology 

Epidemiology of non-alcoholic fatty liver disease (NALFD)

Dr Philip Newsome, Director, Centre for Liver and Gastrointestinal Research and Professor of Hepatology, University of Birmingham, Consultant Hepatologist, Queen Elizabeth Hospital

MDT approach to NAFLD and diabetes: Scoring systems in NAFLD

Dr Michael Yee, Consultant Diabetologist, St Mary's Hospital

Biochemistry and imaging in NAFLD

Dr Pinelopi Mansousou, Consultant Hepatologist, Honorary Senior Lecturer, St Mary's Hospital

Pathology in NAFLD

Professor Rob Goldin, Consultant Histopathologist, Imperial College London

Panel discussion
Close of meeting
View the programme 27 April 2022

Welcome and introduction

Dr Stella George, Consultant in Diabetes and Endocrinology, President, Endocrinology and Diabetes Section, Royal Society of Medicine and Dr Helen Turner, Consultant in Endocrinology

Case finding, risk stratification and clinical management

Dr Jeremy Cobbold, Consultant Hepatologist and Honorary Senior Lecturer, John Radcliffe Hospital

Newer therapies in NAFLD

Dr Jeremy Tomlinson, Professor of Metabolic Endocrinology, University of Oxford

Panel discussion
Close of meeting
View the programme 28 April 2022

Welcome and introduction

Dr Stella George, Consultant in Diabetes and Endocrinology, President, Endocrinology and Diabetes Section, Royal Society of Medicine and Dr Sheba Jarvis, Consultant in Diabetes and Endocrinology 

The microbiome in NAFLD

Dr Debbie Shawcross, Professor of Hepatology and Chronic Liver Failure, Institute of Liver Studies, King’s College Hospital NHS Foundation Trust

The effect of diabetes therapies on NAFLD

Professor Dan Cuthbertson, Institute of Life Course and Medical Sciences, University of Liverpool

Biomarkers, metabolomics and NAFLD

Dr Ahmad Moolla, Associate Professor of Medicine, Newcastle University Medicine Malaysia

Panel discussion
Close of meeting




Registration for this webinar will close 1 hour prior to the start time. You will receive the webinar link 1 hour before the meeting. Late registrations will not be accepted. 

Webinar recordings will be available for registered delegates up to 60 days after the live webinar, via Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.  

Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member